Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Vortioxetine> ?p ?o. }
Showing items 1 to 79 of
79
with 100 items per page.
- Vortioxetine abstract "Vortioxetine (vor-tye-OX-e-teen, trade name Brintellix, previously known as Lu AA21004) is an atypical antidepressant made by Lundbeck and Takeda. On September 30, 2013, it was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults. Vortioxetine was also investigated as a treatment for generalized anxiety disorder (GAD).Following a positive opinion by the Committee for Medicinal Products for Human Use (CHMP) in October 2013, Lundbeck announced December 27, 2013, that European marketing authorization for Brintellix had been obtained.Filing for Canada should follow. Filing for the Japanese market is expected in 2013.".
- Vortioxetine atcPrefix "N06".
- Vortioxetine atcSuffix "AX26".
- Vortioxetine bioavailability "75.0".
- Vortioxetine casNumber "508233-74-7".
- Vortioxetine chEBI "76016".
- Vortioxetine iupacName "1-[2-(2,4-Dimethyl-phenylsulfanyl)-phenyl]piperazine".
- Vortioxetine pubchem "9966051".
- Vortioxetine thumbnail Lu_AA21004.svg?width=300.
- Vortioxetine wikiPageID "26117294".
- Vortioxetine wikiPageRevisionID "603869309".
- Vortioxetine atcPrefix "N06".
- Vortioxetine atcSuffix "AX26".
- Vortioxetine bioavailability "75.0".
- Vortioxetine c "18".
- Vortioxetine casNumber "508233".
- Vortioxetine chebi "76016".
- Vortioxetine chemspiderid "8141643".
- Vortioxetine eliminationHalfLife "237600.0".
- Vortioxetine excretion "59".
- Vortioxetine h "22".
- Vortioxetine hasPhotoCollection Vortioxetine.
- Vortioxetine image "Vortioxetine3Dan.gif".
- Vortioxetine inchi "1".
- Vortioxetine inchikey "YQNWZWMKLDQSAC-UHFFFAOYAJ".
- Vortioxetine iupacName "1".
- Vortioxetine kegg "D10184".
- Vortioxetine legalStatus "Rx-only".
- Vortioxetine licenceEu "Brintellix".
- Vortioxetine licenceUs "Vortioxetine".
- Vortioxetine metabolism "extensive hepatic, primarily CYP2D6-mediated oxidation".
- Vortioxetine molecularWeight "298.45".
- Vortioxetine n "2".
- Vortioxetine pregnancyUs "C".
- Vortioxetine proteinBound "98.0".
- Vortioxetine pubchem "9966051".
- Vortioxetine routesOfAdministration Mouth.
- Vortioxetine s "1".
- Vortioxetine smiles "CC=C1SC2=CC=CC=C2".
- Vortioxetine stdinchi "1".
- Vortioxetine stdinchikey "YQNWZWMKLDQSAC-UHFFFAOYSA-N".
- Vortioxetine synonyms "Lu AA21004".
- Vortioxetine tradename "Brintellix".
- Vortioxetine verifiedfields "changed".
- Vortioxetine verifiedrevid "454958164".
- Vortioxetine watchedfields "changed".
- Vortioxetine width "175".
- Vortioxetine width "200".
- Vortioxetine subject Category:Antidepressants.
- Vortioxetine subject Category:Anxiolytics.
- Vortioxetine subject Category:Piperidines.
- Vortioxetine subject Category:Serotonin_reuptake_inhibitors.
- Vortioxetine subject Category:Sulfides.
- Vortioxetine type Agent114778436.
- Vortioxetine type CausalAgent100007347.
- Vortioxetine type Drug103247620.
- Vortioxetine type Matter100020827.
- Vortioxetine type Medicine103740161.
- Vortioxetine type PhysicalEntity100001930.
- Vortioxetine type Piperazine103946814.
- Vortioxetine type Piperazines.
- Vortioxetine type Substance100020090.
- Vortioxetine type Vermifuge104528630.
- Vortioxetine type Drug.
- Vortioxetine type FunctionalSubstance.
- Vortioxetine comment "Vortioxetine (vor-tye-OX-e-teen, trade name Brintellix, previously known as Lu AA21004) is an atypical antidepressant made by Lundbeck and Takeda. On September 30, 2013, it was approved by the U.S. FDA for the treatment of major depressive disorder (MDD) in adults.".
- Vortioxetine label "Vortioxetina".
- Vortioxetine label "Vortioxetine".
- Vortioxetine label "Vortioxétine".
- Vortioxetine sameAs Vortioxétine.
- Vortioxetine sameAs Vortioxetina.
- Vortioxetine sameAs Wortioksetyna.
- Vortioxetine sameAs m.0b6lwps.
- Vortioxetine sameAs Q3563148.
- Vortioxetine sameAs Q3563148.
- Vortioxetine sameAs Vortioxetine.
- Vortioxetine wasDerivedFrom Vortioxetine?oldid=603869309.
- Vortioxetine depiction Lu_AA21004.svg.
- Vortioxetine isPrimaryTopicOf Vortioxetine.